Eprotirome with statin therapy

Links shared publicly online about this topic.

  • 1,324
    total visits

Eprotirome with statin therapy

theheart.org

The thyroid hormone analog further reduced total- and LDL-cholesterol levels, as well as triglycerides, without any adverse effects. Commonly observed side effects of past thyroid hormone mimetics have included a rapid heart rate or atrial dysrhythmias, but these were not reported with eprotirome.

View full resource at theheart.org

Tags: Heart, Arrhythmia, Cholesterol, Hormone

  • Share

Most Recently Shared on March 10, 2010 at 10:07 pm By:

theheartorg Shelley Wood

Eprotirome further reduces cholesterol levels in statin-treated patients: The thyroid hormone analog further redu... http://bit.ly/a1NWnl

2 years ago...

theheart.org: trusted cardiology news and opinions

theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on April 4, 2012 at 10:59 am By:

Rheumatoid Arthritis Patients At Increased Mortality Risk If They Stop Their Statin Therapy

medicalnewstoday.com — “Patients with rheumatoid arthritis (RA) who discontinue use of statin therapy are at increased risk of death from cardiovascular disease and other causes. According to the findings of a populationView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 29, 2012 at 8:05 am By:

mnt_statins MNT Statins News Health News

Rheumatoid Arthritis Patients At Increased Mortality Risk If They Stop Their Statin Therapy http://t.co/t9WabUBS #statins

2 months ago...

Stopping statin therapy increases risk of death for rheumatoid arthritis patients

medicalxpress.com — “Patients with rheumatoid arthritis (RA) who discontinue use of statin therapy are at increased risk of death from cardiovascular disease and other causes. According to the findings of a population-based study now available in Arthritis Care & Research, a journal published by Wiley-Blackwell on behalf ...View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on March 28, 2012 at 7:35 am By:

physorg_health PhysOrg Health News Health News

Stopping statin therapy increases risk of death for rheumatoid arthritis patients http://t.co/VyQHNKu7

2 months ago...

Stopping statin therapy increases risk of death for rheumatoid arthritis patients

eurekalert.org — “Patients with rheumatoid arthritis who discontinue use of statin therapy are at increased risk of death from cardiovascular disease and other causes. According to the findings of a population-based study now available in Arthritis Care & Research, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology, RA patients should be advised of the importance of compliance to their statin therapy to reduce cardiovascular disease mortality risk.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on March 28, 2012 at 5:54 am By:

RA_Wisdom OrganizedWisdom RA OW Health

Stopping statin therapy increases risk of death for rheumatoid arthritis patients: ( Wiley-Blackwell ) Patients ... http://t.co/hI29t2Dp

2 months ago...

Stopping statin therapy increases risk of death for rheumatoid arthritis patients

eurekalert.org — “Patients with rheumatoid arthritis who discontinue use of statin therapy are at increased risk of death from cardiovascular disease and other causes. According to the findings of a population-based study now available in Arthritis Care & Research, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology, RA patients should be advised of the importance of compliance to their statin therapy to reduce cardiovascular disease mortality risk.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on March 28, 2012 at 4:52 am By:

eurekalert science news Health News

AAAS Stopping statin therapy increases risk of death for rheumatoid arthritis patients http://t.co/9qIG698Z

2 months ago...

ACC: Biologic Wows for Lipid Lowering (CME/CE) - QualityPoint Technologies

qualitypointtech.net — “CHICAGO (MedPage Today) -- A novel monoclonal antibody when added to statin therapy substantially cuts LDL cholesterol levels beyond reductions achieved with statin therapy alone, a phase II study found.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on March 27, 2012 at 1:00 am By:

MedicalFeed MedicalFeed Health News Feed

ACC: Biologic Wows for Lipid Lowering (CME/CE): CHICAGO (MedPage Today) -- A novel monoclonal antibody when added ... http://t.co/cOPzpZtL

2 months ago...

Antibody injection lowers LDL, adding to effectiveness of statin therapy

medicalxpress.com — “A novel monoclonal antibody identified in a new study dramatically lowered circulating LDL cholesterol by 40 percent to 72 percent, a development with potential to provide a new option for patients who are resistant to cholesterol-lowering drugs such as statins or to the current standard of care, according ...View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 4:37 pm By:

physorg_health PhysOrg Health News Health News

Antibody injection lowers LDL, adding to effectiveness of statin therapy http://t.co/6ObXB59K

2 months ago...

Intensive statin therapy, compared with moderate dose, increases risk of new onset diabetes but decreases risk of cardiovascular events -- Rajpathak 17 (2): 55 -- Evidence-Based Medicine

ebm.bmj.com — “Intensive statin therapy, compared with moderate dose, increases risk of new onset diabetes but decreases risk of cardiovascular events -- Rajpathak 17 (2): 55 -- Evidence-Based MedicineView full resource at ebm.bmj.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 2:50 am By:

HeartDisease_OW Heart Disease OW OW Health

Intensive statin therapy, compared with moderate dose, increases risk of new onset diabetes but decreases risk o... http://t.co/EmpJvnWm

2 months ago...

Statin Therapy: Assessing Intolerance, Drug Interactions, and Use in Renal Insufficiency | LinkedIn

events.linkedin.com — “PROGRAM OVERVIEW Statins dramatically reduce cardiovascular risk by lowering LDL-C levels, however, their use in some patients requires additional considerations, such as those with chronic kidney disease. In addition, there are significant safety and efficacy differences within the class that must be understood to ensure patients receive the optimal therapy and cardioprotective benefits of the class of drugs. Newer statins can achieve more pronounced LDL-C reductions at lower dosages, reducing View full resource at events.linkedin.com

  • View Related
  • Share

Most Recently Shared on March 25, 2012 at 3:44 pm By:

lipiddoc James Underberg Internist, Physician, and Doctor

LinkedIn Events: Statin Therapy: Assessing Intolerance, Drug Interactions, and Use in Renal Insufficiency http://t.co/HLehljFL

2 months ago...

Reasons to Abandon Low-Density Lipoprotein Targets | CurrentMedicine.tv

currentmedicine.tv — “Interviewed by Steven Greer, MD (In full screen 1080i HD) http://youtu.be/gpdAdkyMemg Harlan Krumholz, MD, cardiologist from Yale, discusses his openView full resource at currentmedicine.tv

  • View Related
  • Share

Most Recently Shared on March 22, 2012 at 1:51 am By:

THEHCC Healthcare Channel Health Site

New Video: Harlan Krumholz of Yale explains why targeting the LDL number is not the best way to guide statin therapies http://t.co/1Pbn4HFn

2 months ago...

Statin Alternative Looks Promising in Early Trials - Yahoo! News

news.yahoo.com — “From Yahoo! News: WEDNESDAY, March 21 (HealthDay News) -- A new anti-cholesterol drug appears safe and effective in people already taking statins such as Lipitor, making it a potential addition to statin therapy or an alternative, a preliminary new study suggests.View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 22, 2012 at 1:51 am By:

Cholesterol_OW Cholesterol OW OW Health

Statin Alternative Looks Promising in Early Trials: WEDNESDAY, March 21 (HealthDay News) -- A new anti-cholester... http://t.co/ev3ciNFS

2 months ago...

Statin Alternative Looks Promising in Early Trials - Yahoo! News

news.yahoo.com — “From Yahoo! News: WEDNESDAY, March 21 (HealthDay News) -- A new anti-cholesterol drug appears safe and effective in people already taking statins such as Lipitor, making it a potential addition to statin therapy or an alternative, a preliminary new study suggests.View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 22, 2012 at 12:23 am By:

HealthTrendster HealthTrendster Health Executive

Statin Alternative Looks Promising in Early Trials - WEDNESDAY, March 21 (HealthDay News) -- A new anti-cholesterol ... http://t.co/mc2Jjmgb

2 months ago...

Statin Alternative Looks Promising in Early Trials - iVillage

ivillage.com — “WEDNESDAY, March 21 (HealthDay News) -- A new anti-cholesterol drug appears safe and effective in people already taking statins such as Lipitor, making it a potential addition to statin therapy or an alternative, a preliminary new study suggests.View full resource at ivillage.com

  • View Related
  • Share

Most Recently Shared on March 22, 2012 at 12:18 am By:

ivillagehealth Your Total Health Health Site

Statin Alternative Looks Promising in Early Trials http://t.co/OuQbWXa7

2 months ago...

Statin Alternative Looks Promising in Early Trials - Drugs.com MedNews

drugs.com — “A new anti-cholesterol drug appears safe and effective in people already taking statins such as Lipitor, making it a potential addition to statin therapy or anView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on March 21, 2012 at 10:58 pm By:

drugscom Drugs.com Health Site

Statin Alternative Looks Promising in Early Trials - http://t.co/rm271jNh

2 months ago...

Lipids in Health and Disease | Abstract | Statin therapy, myopathy and exercise--A case report

lipidworld.com — “In a bid to reduce the morbidity and mortality associated with coronary artery disease, statin therapy has become a cornerstone treatment for patients with dyslipideamia. Statins, or HMG-CoA reductase inhibitors, are effective in blocking hepatic synthesis of cholesterol and are generally regarded as safe. Although rare, severe adverse side effects such as rhabdomyolysis have been reported, however, the more common complaint from patients is that related to myopathy. There is also mounting evideView full resource at lipidworld.com

  • View Related
  • Share

Most Recently Shared on March 16, 2012 at 1:20 pm By:

BioMedCentral BioMed Central Medical Journal

Short report: #Statin therapy, myopathy and exercise http://t.co/Sr4iEJ3m from Lipids in #Health & Disease #coronaryarterydisease

3 months ago...

Advertisement